Prednisolone inhibits PDGF-induced nuclear translocation of NF-κB in human pulmonary artery smooth muscle cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 295, Issue 4, 2008, Pages

  Ogawa, Aiko ^a   Firth, Amy L ^a   Yao, Weijuan ^a   Rubin, Lewis J ^a   Yuan, Jason X J ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Immunosuppressant; Proliferation; Pulmonary arterial hypertension; Therapy

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PREDNISOLONE; PROTEIN P50; SYNAPTOTAGMIN I; ANTIOXIDANT; DRUG DERIVATIVE; PROLINE; PROLINEDITHIOCARBAMATE; THIOCARBAMIC ACID DERIVATIVE; THYMIDINE; TRANSIENT RECEPTOR POTENTIAL CHANNEL 3; TRANSIENT RECEPTOR POTENTIAL CHANNEL C; TRANSIENT RECEPTOR POTENTIAL CHANNEL RELATED PROTEIN 1; TRANSIENT RECEPTOR POTENTIAL CHANNEL-RELATED PROTEIN 1; TRPC4 ION CHANNEL; TRPC6 PROTEIN, HUMAN;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD VESSEL WALL; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; DNA SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOSUPPRESSIVE TREATMENT; LUNG BLOOD VESSEL; LUNG VASCULAR RESISTANCE; MITOGENESIS; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; REAL TIME POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; WESTERN BLOTTING; CELL CULTURE; CELL DIVISION; CULTURE MEDIUM; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; METABOLISM; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE;

ANTIOXIDANTS; CELL DIVISION; CELLS, CULTURED; CULTURE MEDIA; HUMANS; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; PLATELET-DERIVED GROWTH FACTOR; PREDNISOLONE; PROLINE; PULMONARY ARTERY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIOCARBAMATES; THYMIDINE; TRPC CATION CHANNELS;

EID: 56149119325     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.90245.2008     Document Type: Article

References (42)

1. Bargou RC, Emmerich F, Krappmann D, Bommert K, Mapara MY, Arnold W, Royer HD, Grinstein E, Greiner A, Scheidereit C, Dorken B. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. J Clin Invest 100: 2961-2969, 1997.
2. Barnes PJ. Inhaled glucocorticoids for asthma. N Engl J Med 332: 868-875, 1995.
3. Barst RJ. PDGF signaling in pulmonary arterial hypertension. J Clin Invest 115: 2691-2694, 2005.
4. Bellotto F, Chiavacci P, Laveder F, Angelini A, Thiene G, Marcolongo R. Effective immunosuppressive therapy in a patient with primary pulmonary hypertension. Thorax 54: 372-374, 1999.
5. Bourcier T, Sukhova G, Libby P. The nuclear factor κB signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis. J Biol Chem 272: 15817-15824, 1997.
6. Buhl R, Farmer SG. Current and future pharmacologic therapy of exacerbations in chronic obstructive pulmonary disease and asthma. Proc Am Thorac Soc 1: 136-142, 2004.
7. Duckett CS, Perkins ND, Leung K, Agranoff AB, Nabel GJ. Cytokine induction of nuclear factor κB in cycling and growth-arrested cells. Evidence for cell cycle-independent activation. J Biol Chem 270: 18836-18840, 1995.
8. Fan J, Ye RD, Malik AB. Transcriptional mechanisms of acute lung injury. Am J Physiol Lung Cell Mol Physiol 281: L1037-L1050, 2001.
9. Garg AK, Aggarwal BB. Reactive oxygen intermediates in TNF signaling. Mol Immunol 39: 509-517, 2002.
10. Gerasimovskaya EV, Ahmad S, White CW, Jones PL, Carpenter TC, Stenmark KR. Extracellular ATP is an autocrine/paracrine regulator of hypoxia-induced adventitial fibroblast growth. Signaling through extracellular signal-regulated kinase-1/2 and the Egr-1 transcription factor. J Biol Chem 277: 44638-44650, 2002.
11. Ghofrani HA, Seeger W, Grimminger F. Imatinib for the treatment of pulmonary arterial hypertension. N Engl J Med 353: 1412-1413, 2005.
12. 2+ entry in human pulmonary artery myocytes during proliferation. Am J Physiol Heart Circ Physiol 280: H746-H755, 2001.
13. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 79: 1283-1316, 1999.
14. Hoshi S, Goto M, Koyama N, Nomoto K, Tanaka H. Regulation of vascular smooth muscle cell proliferation by nuclear factor-κB and its inhibitor, IκB. J Biol Chem 275: 883-889, 2000.
15. Humbert M, Monti G, Fartoukh M, Magnan A, Brenot F, Rain B, Capron F, Galanaud P, Duroux P, Simonneau G, Emilie D. Platelet-derived growth factor expression in primary pulmonary hypertension: comparison of HIV seropositive and HIV seronegative patients. Eur Respir J 11: 554-559, 1998.
16. Jobin C, Haskill S, Mayer L, Panja A, Sartor RB. Evidence for altered regulation of IκB alpha degradation in human colonic epithelial cells. J Immunol 158: 226-234, 1997.
17. Laan RF, Jansen TL, van Riel PL. Glucocorticosteroids in the management of rheumatoid arthritis. Rheumatology (Oxford) 38: 6-12, 1999.
18. Lavie J, Dandre F, Louis H, Lamaziere JM, Bonnet J. Vascular cell adhesion molecule-1 gene expression during human smooth muscle cell differentiation is independent of NF-κB activation. J Biol Chem 274: 2308-2314, 1999.
19. Levy NT, Liapis H, Eisenberg PR, Botney MD, Trulock EP. Pathologic regression of primary pulmonary hypertension in left native lung following right single-lung transplantation. J Heart Lung Transplant 20: 381-384, 2001.
20. Liakopoulos OJ, Teucher N, Muhlfeld C, Middel P, Heusch G, Schoendube FA, Dorge H. Prevention of TNFα-associated myocardial dysfunction resulting from cardiopulmonary bypass and cardioplegic arrest by glucocorticoid treatment. Eur J Cardiothorac Surg 30: 263-270, 2006.
21. Liu SF, Ye X, Malik AB. Inhibition of NF-κB activation by pyrrolidine dithiocarbamate prevents in vivo expression of proinflammatory genes. Circulation 100: 1330-1337, 1999.
22. Mehrhof FB, Schmidt-Ullrich R, Dietz R, Scheidereit C. Regulation of vascular smooth muscle cell proliferation: role of NF-κB revisited. Circ Res 96: 958-964, 2005.
23. Mills JA. Systemic lupus erythematosus. N Engl J Med 330: 1871-1879, 1994.
24. Morton JM, Williamson S, Kear LM, McWhinney BC, Potter J, Glanville AR. Therapeutic drug monitoring of prednisolone after lung transplantation. J Heart Lung Transplant 25: 557-563, 2006.
25. Obata H, Biro S, Arima N, Kaieda H, Kihara T, Eto H, Miyata M, Tanaka H. NF-κB is induced in the nuclei of cultured rat aortic smooth muscle cells by stimulation of various growth factors. Biochem Biophys Res Commun 224: 27-32, 1996.
26. Ogawa A, Nakamura K, Matsubara H, Fujio H, Ikeda T, Kobayashi K, Miyazaki I, Asanuma M, Miyaji K, Miura D, Kusano KF, Date H, Ohe T. Prednisolone inhibits proliferation of cultured pulmonary artery smooth muscle cells of patients with idiopathic pulmonary arterial hypertension. Circulation 112: 1806-1812, 2005.
27. Palombella VJ, Rando OJ, Goldberg AL, Maniatis T. The ubiquitin-proteasome pathway is required for processing the NF-κB1 precursor protein and the activation of NF-κB. Cell 78: 773-785, 1994.
28. Pui CH, Evans WE. Treatment of acute lymphoblastic leukemia. N Engl J Med 354: 166-178, 2006.
29. Sanchez O, Marcos E, Perros F, Fadel E, Tu L, Humbert M, Dartevelle P, Simonneau G, Adnot S, Eddahibi S. Role of endothelium-derived CC chemokine ligand 2 in idiopathic pulmonary arterial hypertension. Am J Respir Crit Care Med 176: 1041-1047, 2007.
30. Sawada H, Mitani Y, Maruyama J, Jiang BH, Ikeyama Y, Dida FA, Yamamoto H, Imanaka-Yoshida K, Shimpo H, Mizoguchi A, Maruyama K, Komada Y. A nuclear factor-κB inhibitor pyrrolidine dithiocarbamate ameliorates pulmonary hypertension in rats. Chest 132: 1265-1274, 2007.
31. Schermuly RT, Dony E, Ghofrani HA, Pullamsetti S, Savai R, Roth M, Sydykov A, Lai YJ, Weissmann N, Seeger W, Grimminger F. Reversal of experimental pulmonary hypertension by PDGF inhibition. J Clin Invest 115: 2811-2821, 2005.
32. Shin HM, Kim MH, Kim BH, Jung SH, Kim YS, Park HJ, Hong JT, Min KR, Kim Y. Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-κB without affecting IκB degradation. FEBS Lett 571: 50-54, 2004.
33. 2+ entry and attenuates pulmonary artery smooth muscle cell proliferation. Am J Physiol Lung Cell Mol Physiol 283: L144-L155, 2002.
34. Toyozaki T, Saito T, Takano H, Yorimitsu K, Kobayashi S, Ichikawa H, Takeda K, Inagaki Y. Expression of intercellular adhesion molecule-1 on cardiac myocytes for myocarditis before and during immunosuppressive therapy. Am J Cardiol 72: 441-444, 1993.
35. Unlap T, Jope RS. Inhibition of NF-κB DNA binding activity by glucocorticoids in rat brain. Neurosci Lett 198: 41-44, 1995.
36. Voisard R, Seitzer U, Baur R, Dartsch PC, Osterhues H, Hoher M, Hombach V. Corticosteroid agents inhibit proliferation of smooth muscle cells from human atherosclerotic arteries in vitro. Int J Cardiol 43: 257-267, 1994.
37. Yu Y, Fantozzi I, Remillard CV, Landsberg JW, Kunichika N, Platoshyn O, Tigno DD, Thistlethwaite PA, Rubin LJ, Yuan JX. Enhanced expression of transient receptor potential channels in idiopathic pulmonary arterial hypertension. Proc Natl Acad Sci USA 101: 13861-13866, 2004.
38. Yu Y, Safrina O, Landsberg JW, Vangala N, Nicholson A, Rubin LJ, Cahalan MD, Yuan JX. A functional single-nucleotide polymorphism (-254 C to G) in the TRPC6 gene is associated with idiopathic pulmonary arterial hypertension. Circulation 114: II-130, 2006.
39. 2+ entry in pulmonary artery smooth muscle cells of idiopathic pulmonary arterial hypertension patients. Circulation 116: II-59-60, 2007.
40. Yu Y, Sweeney M, Zhang S, Platoshyn O, Landsberg J, Rothman A, Yuan JX. PDGF stimulates pulmonary vascular smooth muscle cell proliferation by upregulating TRPC6 expression. Am J Physiol Cell Physiol 284: C316-C330, 2003.
41. Zhang S, Remillard CV, Fantozzi I, Yuan JX. ATP-induced mitogenesis is mediated by cyclic AMP response element-binding protein-enhanced TRPC4 expression and activity in human pulmonary artery smooth muscle cells. Am J Physiol Cell Physiol 287: C1192-C1201, 2004.
42. Zuckermann A, Reichenspurner H, Birsan T, Treede H, Deviatko E, Reichart B, Klepetko W. Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial. J Thorac Cardiovasc Surg 125: 891-900, 2003.